Morgan Stanley
AEON icon

Morgan Stanley’s AEON Biopharma AEON Stock Holding History

Morgan Stanley’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108 Hold
150
– – ﹤0.01% 7933
2026
Q1 		$148 Hold
150
– – ﹤0.01% 7735
2025
Q4 		$165 Hold
150
– – ﹤0.01% 7651
2025
Q3 		$121 Hold
150
– – ﹤0.01% 7656
2025
Q2 		$114 Hold
150
– – ﹤0.01% 7635
2025
Q1 		$87 Sell
150
-1
-0.7% -$7 ﹤0.01% 7595
2024
Q4 		$5.87K Buy
151
+126
+504% +$7.34K ﹤0.01% 6964
2024
Q3 		$1.89K Hold
25
– – ﹤0.01% 7141
2024
Q2 		$1.89K Sell
25
-120
-83% -$28.6K ﹤0.01% 7076
2024
Q1 		$121K Buy
145
+120
+480% +$86.9K ﹤0.01% 5915
2023
Q4 		$13K Buy
+25
New +$10K ﹤0.01% 6567

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley's AEON Position: Q2 2026 in Review

Morgan Stanley held its AEON Biopharma (AEON) position steady in Q2 2026 at 150 shares worth $108. The position accounts for ﹤0.01% of the portfolio, ranked #7933.

Morgan Stanley first reported a position in AEON in Q4 2023 and has held it in 11 quarters since. The position peaked at $121K in Q1 2024. 22 funds tracked by Wall St. Rank hold AEON as of Q2 2026.

  • Morgan Stanley held 150 shares of AEON Biopharma worth $108 as of Q2 2026.
  • Morgan Stanley left its AEON Biopharma share count unchanged in Q2 2026.
  • AEON Biopharma made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7933 holding.
  • Morgan Stanley first reported a position in AEON Biopharma in Q4 2023 and has held it in 11 quarters since.
  • Morgan Stanley's AEON Biopharma position peaked at $121K in Q1 2024.
  • 22 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.